Pine Bridge Investments, L.P. Exelixis, Inc. Transaction History
Pine Bridge Investments, L.P.
- $12.9 Billion
- Q4 2024
A detailed history of Pine Bridge Investments, L.P. transactions in Exelixis, Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 149,367 shares of EXEL stock, worth $5.52 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
149,367
Previous 189,553
21.2%
Holding current value
$5.52 Million
Previous $4.92 Million
1.12%
% of portfolio
0.04%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.24 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.09 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$866 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$565 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$422 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...